NELL-1相关膜性肾病的发现与鉴定
本研究通过激光微切割肾小球联合质谱分析,在PLA2R阴性膜性肾病患者中鉴定出新型靶抗原NELL-1。126例PLA2R阴性患者中29例NELL-1阳性,验证队列84例中5例阳性,血清抗NELL-1抗体阳性,提示NELL-1定义了一种独特的原发性膜性肾病类型。
要点
- NELL-1是PLA2R阴性原发性膜性肾病的新型靶抗原。
- NELL-1与IgG共定位于肾小球基底膜,血清可检出抗NELL-1抗体。
- NELL-1阳性膜性肾病临床和病理表现符合原发性膜性肾病。
核心结论
- NELL-1在部分PLA2R阴性膜性肾病患者中与IgG共定位于肾小球基底膜,并伴有血清抗NELL-1抗体,定义了一种独特的原发性膜性肾病类型。
研究设计与样本
- 研究采用激光微切割肾小球后质谱分析鉴定PLA2R阴性膜性肾病的新抗原,包括初步质谱研究、发现队列和法国及比利时的两个验证队列。
主要发现
- 初步质谱研究35例PLA2R阴性膜性肾病中6例NELL-1光谱计数高,23例PLA2R相关膜性肾病和88例对照未检出NELL-1。
- 发现队列91例PLA2R阴性膜性肾病中23例免疫组化NELL-1阳性,其中14例经质谱确认,合计126例中29例NELL-1阳性。
- 两个验证队列84例PLA2R和THSD7A阴性膜性肾病中5例NELL-1阳性。
- 共聚焦显微镜显示IgG和NELL-1共定位于肾小球基底膜,免疫印迹显示5份血清对NELL-1有反应性而对照血清无反应。
- NELL-1阳性膜性肾病的临床和活检特征符合原发性膜性肾病。
关键数值与推荐
- PLA2R和THSD7A分别是70%和1-5%原发性膜性肾病的靶抗原。
- 126例PLA2R阴性膜性肾病中29例NELL-1阳性。
- 两个验证队列84例PLA2R和THSD7A阴性膜性肾病中5例NELL-1阳性。
临床怎么用
- 对PLA2R阴性的原发性膜性肾病患者,可考虑检测NELL-1抗原或血清抗NELL-1抗体以明确病因。
局限性
- 研究未报告NELL-1阳性患者的长期预后或治疗反应数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Membranous nephropathy is characterized by deposition of immune complexes along the glomerular basement membrane. PLA2R and THSD7A are target antigens in 70% and 1-5% of primary membranous nephropathy cases, respectively. In the remaining cases, the target antigen is unknown. Here, laser microdissection of glomeruli followed by mass spectrometry was used to identify novel antigen(s) in PLA2R-negative membranous nephropathy. An initial pilot mass spectrometry study in 35 cases of PLA2R-negative membranous nephropathy showed high spectral counts for neural tissue encoding protein with EGF-like repeats, NELL-1, in six cases. Mass spectrometry failed to detect NELL-1 in 23 PLA2R-associated membranous nephropathy and 88 controls. NELL-1 was localized by immunohistochemistry, which showed bright granular glomerular basement membrane staining for NELL-1 in all six cases. Next, an additional 23 NELL-1 positive cases of membranous nephropathy were identified by immunohistochemistry in a discovery cohort of 91 PLA2R-negative membranous nephropathy cases, 14 were confirmed by mass spectrometry. Thus, 29 of 126 PLA2R-negative cases were positive for NELL-1. PLA2R-associated membranous nephropathy and controls stained negative for NELL-1. We then identified five NELL-1 positive cases of membranous nephropathy out of 84 PLA2R and THSD7A-negative cases in two validation cohorts from France and Belgium. By confocal microscopy, both IgG and NELL-1 co-localized to the glomerular basement membrane. Western blot analysis showed reactivity to NELL-1 in five available sera, but no reactivity in control sera. Clinical and biopsy findings of NELL-1 positive membranous nephropathy showed features of primary membranous nephropathy. Thus, a subset of membranous nephropathy is associated with accumulation and co-localization of NELL-1 and IgG along the glomerular basement membrane, and with anti-NELL-1 antibodies in the serum. Hence, NELL-1 defines a distinct type of primary membranous nephropathy.
引用
- Sethi S, Debiec H, Madden B, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy. Kidney Int. 2019. PMID: 31901340. doi:10.1016/j.kint.2019.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。